According to a report published in Nature last week, 72% of drug makers surveyed (respondents included company executives and recruiters) intend to boost their research capacity in the next 12 months by hiring scientists, creating partnerships or improving infrastructure. Further, additional survey results suggested that jobs will grow by 30% among US medical scientists, biochemists and biophysicists by 2020. While I have not read the entire report, it seems to me that asking company executives (responsible for company growth and maintaining stock share price) and recruiters (who make a living finding difficult to find employees for drug companies) may not provide survey readers with accurate information that one could use for trend analysis.
Nevertheless, despite the rosy proclamations made in the report, there are a few caveats. First, the 30% increase in hiring by 2020 includes mainly medical scientists (clinical personnel), biophysicists (how many biophysicists are there anyway) and biochemists (are there any really left?). What about all the molecular biologists, bioinformatics and genomics scientists, physiologists, pharmacologists etc etc?
Second and perhaps most revealing, survey respondents noted that the types of scientists that they want to hire are those who 1) “can develop and manage external partnerships” (translation: business development, marketing, brand managers etc); 2) “know about regulatory science” and 3) “can manage and analyze big data sets and outcomes research.” I don’t know about you, but I did not learn any of the above mentioned desirable skills while working on my PhD degree.
Finally, one of the report authors opined that early career scientists looking for employment opportunities need to “think about the entire value chain that leads to the development of a drug or medical device.” Really? First, what is a value chain and second who is going to teach graduate students and postdocs how drugs and devices are developed when nobody at their institution knows how to develop drugs and devices since they work in academia and not industry? Interestingly, I know many pharmaceutical and biotechnology company employees who don’t really understand the complete drug/device development process because things are done in silos at most drug and devices companies.
The point that I am trying to make, is that nobody can predict what the job market for life sciences professionals will be in 2020. The best advice that I can give is to develop a career plan, remain flexible and have at least two or three contingency in place!
Until next time,
Good Luck and Good Job Hunting!!!!!!